**Core Concept**
Wilson disease is a genetic disorder characterized by excessive accumulation of copper in the body, particularly in the liver, brain, and other vital organs. Zinc therapy plays a crucial role in managing this condition by inducing intestinal metallothionein synthesis, which binds excess copper and prevents its absorption.

**Why the Correct Answer is Right**
Zinc therapy has several advantages in the management of Wilson disease. It helps in reducing copper absorption from the intestine, thereby decreasing the accumulation of toxic copper in the body. Additionally, zinc therapy induces the synthesis of metallothionein, a protein that binds copper and prevents its absorption. This mechanism helps in stabilizing the neurological symptoms and slowing the progression of liver disease. Zinc therapy also helps in reducing the need for frequent blood transfusions and liver transplantation.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while zinc therapy may have some effects on the gastrointestinal system, it is not a primary advantage in the management of Wilson disease.
**Option B:** This option is incorrect because while penicillamine is a treatment for Wilson disease, it is not an advantage of zinc therapy.
**Option C:** This option is incorrect because while liver transplantation is a treatment option for Wilson disease, it is not an advantage of zinc therapy.

**Clinical Pearl / High-Yield Fact**
One of the key high-yield facts to remember is that zinc therapy is effective in managing Wilson disease because it induces intestinal metallothionein synthesis, which binds excess copper and prevents its absorption. This mechanism helps in reducing the accumulation of toxic copper in the body and stabilizing the neurological symptoms.

**Correct Answer: D. All of the above.**